Skip to content
Brand AI

Pfizer-BioNTech

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2022

    Alnylam sues Moderna and Pfizer over lipid patent

    Lawsuit filed

    Alnylam filed lawsuits against Moderna and Pfizer in federal court in Delaware, alleging that their COVID-19 vaccines infringe its biodegradable-lipids patent. Alnylam said it was seeking monetary relief and did not want to impede vaccine sales, production or distribution. Moderna denied the allegation; Pfizer had not commented to the outlet.

    Company response

    • Denial — Moderna

      “Moderna’s LNPs do not resemble Alnylam’s work, and any assertion that the Alnylam patent covers Moderna’s Covid-19 vaccine is specious,” the company said.

    Source excerpt

    • Alnylam alleges that the company’s FDA-approved Covid vaccine, Spikevax, uses biodegradable LNP technology that infringes on the biodegradable lipids patent.
    • The two lawsuits were filed Thursday in federal court in Delaware.
    • Alnylam did not have similar meetings with Pfizer or BioNTech, but the company claims that their FDA-approved Covid vaccine, Comirnaty, uses LNPs that infringe the same patent.
    Source